Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin
20-lyase inhibitors
486427-17-2
The plasma clearance is high at 3
it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle
MK 2206 Size:Solid 10 mg is a semisynthetic derivative ofMK2206 is a Akt inhibitor, is also an orally bioavailable allosteric inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non ATP competitive manner, which may result in the inhibition of the PI3K Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Product information CAS Number:
US$ 139.00
US$ 85.00
US$ 110.00
US$ 119.00
US$ 109.00
US$ 89.00
US$ 99.00